Urolog. pro Praxi, 2009; 10(5): 269-273

Controversy and discrepance of overactive bladder

MUDr. Radovan Vrtal Ph.D
Urologická klinika FN a LF UP v Olomouci

Overactive bladder (OAB) is chronical and most exhausting dissease of lower urinary tract. Prevalence is more than 16 % of whole community.

In most of cases we don´t be able to detect ethiology of overactive bladder. OAB is defined as a complex of symptoms with their

specific signs. To this time it is not known exact etiology and pathophysiology. We can use standardised diagnostics and treatment

algorithms. The last valid terminology ICS is from 2002.

Keywords: overactive bladder, frequency, urgency, incontinence, nycturie.

Published: December 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vrtal R. Controversy and discrepance of overactive bladder. Urol. praxi. 2009;10(5):269-273.
Download citation

References

  1. Hashim H, Abrams P. Is the bladder a reliable witness for predicting detrusor overactivity? J. Urol, 2006; 176(3): 1255-1257. Go to original source... Go to PubMed...
  2. Vella M, Robinson D, Cardozo L, Srikrishna S, Cartwright R. Predicting detrusor overactivity using a physician-based scoring system. Int Urogynecol J Pelvic Floor Dysfunct. 2008; 19(9): 1223-1227. Go to original source... Go to PubMed...
  3. Chapple ChR, Artibani W, Castro Diaz D, Craggs M, Haab F, Khullar V, Versi E. The role of urinary urgency and its measurement in the overactive bladder symptom syndrome: current concepts and future prospects. BJU Int 2005; 95: 335-340. Go to original source... Go to PubMed...
  4. Lowenstein L, Fitzgerald MP, Kenton K, Brubaker L, Gruenwald I, Papier I, Elliot CH, Mueller ER, Vardi Y. Validation of realtime urodynamic measure of urinary sensation. Am. J. Obst Gynaecol. 2008; 198/6: 661-665. Go to original source... Go to PubMed...
  5. Wein AJ, Rackley RR. Overactive bladder: a better understanding of pathophysiology, diagnosis and management. J Urol 2006: 175: 5-10. Go to original source... Go to PubMed...
  6. Skoupá J. Hyperaktivní měchýř: nákladová efektivita oxybutininu IR a solifenacinu. Urolog. pro Praxi, 2008; 9(2): 61-63.




Urology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.